investing.com/news/economy/us-court-bars-martin-shkreli-from-pharma-industry-orders-646-million-payment-2739542

WASHINGTON - A U.S. court said on Friday that Martin Shkreli, who famously raised the price of Daraprim, would be ordered to pay $64.6 million and would be barred for life from the pharmaceutical industry.

The drug is used to treat toxoplasmosis, a parasitic infection that threatens people with weakened immune systems.

By Nate Raymond BOSTON (Reuters) -Prosecutors have recommended that the U.S. Justice Department drop charges against a Massachusetts Institute of Technology professor accused of...

By Steve Holland WASHINGTON (Reuters) -The United States is concerned that Russia is preparing for an invasion of Ukraine soon by fabricating a pretext for war if diplomacy fails...

By Tyler Clifford and Steve Gorman (Reuters) -Baltimore State's Attorney Marilyn Mosby, the city's top prosecutor, was indicted on Thursday on federal charges of perjury and...

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.

Stay focused and on track. Only post material that’s relevant to the topic being discussed.

Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Tap to copy the Short Url to this post:
bto.sh/z7ckejer 
All Business News on a Single Page. Join for Free →